NO900392D0 - Heparinderivater og fremgangsmaate til fremstilling derav. - Google Patents

Heparinderivater og fremgangsmaate til fremstilling derav.

Info

Publication number
NO900392D0
NO900392D0 NO900392A NO900392A NO900392D0 NO 900392 D0 NO900392 D0 NO 900392D0 NO 900392 A NO900392 A NO 900392A NO 900392 A NO900392 A NO 900392A NO 900392 D0 NO900392 D0 NO 900392D0
Authority
NO
Norway
Prior art keywords
comprised
derivatives
heparins
heparinic derivatives
heparinic
Prior art date
Application number
NO900392A
Other languages
English (en)
Other versions
NO900392L (no
NO301719B1 (no
Inventor
Silvano Piani
Gian Franco Tamagnone
Raul Roberto Alpino
Maria Rita Milani
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Publication of NO900392D0 publication Critical patent/NO900392D0/no
Publication of NO900392L publication Critical patent/NO900392L/no
Publication of NO301719B1 publication Critical patent/NO301719B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
NO900392A 1989-01-30 1990-01-29 Analogifremgangsmåte til fremstilling av terapeutisk aktive heparinderivater NO301719B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8903328A IT1234826B (it) 1989-01-30 1989-01-30 Derivati eparinici e procedimento per la loro preparazione

Publications (3)

Publication Number Publication Date
NO900392D0 true NO900392D0 (no) 1990-01-29
NO900392L NO900392L (no) 1990-07-31
NO301719B1 NO301719B1 (no) 1997-12-01

Family

ID=11105069

Family Applications (1)

Application Number Title Priority Date Filing Date
NO900392A NO301719B1 (no) 1989-01-30 1990-01-29 Analogifremgangsmåte til fremstilling av terapeutisk aktive heparinderivater

Country Status (18)

Country Link
US (1) US5104860A (no)
EP (1) EP0380943B1 (no)
JP (1) JPH0678369B2 (no)
KR (1) KR0161667B1 (no)
AT (1) ATE111107T1 (no)
AU (1) AU610034B2 (no)
CA (1) CA2007616C (no)
DE (1) DE69012154T2 (no)
DK (1) DK0380943T3 (no)
ES (1) ES2058609T3 (no)
FI (1) FI96425C (no)
IE (1) IE66563B1 (no)
IL (1) IL92912A (no)
IT (1) IT1234826B (no)
NO (1) NO301719B1 (no)
NZ (1) NZ232115A (no)
PT (1) PT92991B (no)
ZA (1) ZA90263B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1234826B (it) * 1989-01-30 1992-05-29 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
US5250519A (en) * 1991-03-29 1993-10-05 Glycomed Incorporated Non-anticoagulant heparin derivatives
IT1254216B (it) * 1992-02-25 1995-09-14 Opocrin Spa Derivati polisaccaridici di eparina, eparan solfato, loro frazioni e frammenti, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT1260136B (it) * 1992-04-17 1996-03-28 Alfa Wassermann Spa Glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonicosostituito con radicali nucleofili in posizione 3
IT1260137B (it) * 1992-04-17 1996-03-28 Alfa Wassermann Spa Glicosaminoglicani semisintetici a struttura eparinica od eparanica modificati nella posizione 2 dell'acido alfa-l-iduronico-2-0-solfato
US5668118A (en) * 1992-07-24 1997-09-16 Cavalier Pharmaceuticals Method of synthesis of 2-O-desulfated Heparin and use thereof for inhibition of elastase and Cathepspin G
US5296471A (en) * 1992-12-22 1994-03-22 Glycomed Incorporated Method for controlling o-desulfation of heparin and compositions produced thereby
US5696100A (en) * 1992-12-22 1997-12-09 Glycomed Incorporated Method for controlling O-desulfation of heparin and compositions produced thereby
US5336620A (en) * 1993-01-27 1994-08-09 American Home Products Corporation Process for the production of an anticoagulant composition
IT1264102B1 (it) * 1993-03-29 1996-09-10 Alfa Wassermann Spa Processo per la sintesi di glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonico sostituito con radicali
IT1264101B1 (it) * 1993-03-29 1996-09-10 Alfa Wassermann Spa Processo per la sintesi di glicosaminoglicani semisintetici a struttura eparinica od eparanica modificati nella posizione 2
US20020055710A1 (en) * 1998-04-30 2002-05-09 Ronald J. Tuch Medical device for delivering a therapeutic agent and method of preparation
BR9713141A (pt) * 1996-11-27 2000-02-08 Rhone Poulenc Rorer Pharma Composição farmcêutica processo e kit para o tratamento ou a prevenção de um quadro fisiológico asociado com um distúrbio isquêmico relacionado com trombose e um paciente, uso de quantidades farmaceuticamente efetivas de um composto com atividade anti-xa e de um composto antagonista de agregação de plaquetas, produto contendo estes compostos, e, uso destes compostos.
US6203536B1 (en) 1997-06-17 2001-03-20 Medtronic, Inc. Medical device for delivering a therapeutic substance and method therefor
US6106454A (en) * 1997-06-17 2000-08-22 Medtronic, Inc. Medical device for delivering localized radiation
US6013099A (en) 1998-04-29 2000-01-11 Medtronic, Inc. Medical device for delivering a water-insoluble therapeutic salt or substance
US7259152B2 (en) 2000-06-07 2007-08-21 Alfa Wasserman, Inc. Methods and compositions using sulodexide for the treatment of diabetic nephropathy
AU2007200688B2 (en) * 2000-09-12 2010-02-04 Massachusetts Institute Of Technology Methods and products related to low molecular weight heparin
US7083937B2 (en) * 2000-09-12 2006-08-01 Massachusetts Institute Of Technology Methods and products related to the analysis of polysaccarides
JP4828795B2 (ja) 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
ATE552004T1 (de) 2005-11-30 2012-04-15 Istituto G Ronzoni Oral verabreichbare heparinderivate
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
EP2526122B1 (en) * 2010-01-19 2020-06-10 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
JPWO2012036152A1 (ja) * 2010-09-14 2014-02-03 国立大学法人 宮崎大学 高純度ヘパリンおよびその製造方法
US9068957B2 (en) 2011-02-21 2015-06-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
SG10201603059YA (en) 2012-05-09 2016-05-30 Cantex Pharmaceuticals Inc Treatment Of Myelosuppression
WO2016133910A1 (en) 2015-02-17 2016-08-25 Cantex Pharmaceuticals, Inc. Treatment of cancers and hematopoietic stem cell disorders privileged by cxcl12-cxcr4 interaction
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
WO2021007429A1 (en) 2019-07-09 2021-01-14 Optimvia Llc Methods for synthesizing anticoagulant polysaccharides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5318520B2 (no) * 1972-07-05 1978-06-15
FR2482611B1 (fr) * 1980-05-14 1986-03-07 Pharmindustrie Nouveaux polysaccharides sulfates, procedes pour leur preparation et leur utilisation comme medicaments
DE3265781D1 (en) * 1981-05-21 1985-10-03 Akzo Nv New anti-thromboticum based on polysacharides, method for its preparation and pharmaceutical compositions
IT1195497B (it) * 1983-03-08 1988-10-19 Opocrin Spa Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina
DE3422518A1 (de) * 1984-06-16 1985-12-19 B. Braun Melsungen Ag, 3508 Melsungen Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
IT1234508B (it) * 1988-06-10 1992-05-19 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
IT1234826B (it) * 1989-01-30 1992-05-29 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione

Also Published As

Publication number Publication date
FI96425C (fi) 1996-06-25
NO900392L (no) 1990-07-31
PT92991B (pt) 1995-12-29
IE900316L (en) 1990-07-30
PT92991A (pt) 1990-07-31
DE69012154T2 (de) 1995-02-23
IT8903328A0 (it) 1989-01-30
ATE111107T1 (de) 1994-09-15
FI900446A0 (fi) 1990-01-29
JPH02240102A (ja) 1990-09-25
IE66563B1 (en) 1996-01-24
ES2058609T3 (es) 1994-11-01
KR900011789A (ko) 1990-08-02
AU4885890A (en) 1990-10-25
ZA90263B (en) 1990-10-31
EP0380943B1 (en) 1994-09-07
CA2007616A1 (en) 1990-07-30
NO301719B1 (no) 1997-12-01
KR0161667B1 (ko) 1998-11-16
FI96425B (fi) 1996-03-15
EP0380943A1 (en) 1990-08-08
DE69012154D1 (de) 1994-10-13
US5104860A (en) 1992-04-14
NZ232115A (en) 1991-05-28
IL92912A (en) 1994-06-24
AU610034B2 (en) 1991-05-09
CA2007616C (en) 1996-05-14
DK0380943T3 (da) 1994-12-19
IT1234826B (it) 1992-05-29
IL92912A0 (en) 1990-09-17
JPH0678369B2 (ja) 1994-10-05

Similar Documents

Publication Publication Date Title
NO900392D0 (no) Heparinderivater og fremgangsmaate til fremstilling derav.
ATE109164T1 (de) Heparinderivate und verfahren zu deren herstellung.
NO305992B1 (no) Halvsyntetiske glykosaminglykosaner med heparin- eller heparanstruktur og fremgangsmåte til fremstilling derav
ATE138925T1 (de) Erythromycinderivate, herstellung und verwendung davon
NO930830D0 (no) Nye beta-aminosyrederivater
FR2665168B1 (fr) Composition comportant un succinoglycane.
KR910007532A (ko) 항트롬보 활성을 지닌 설페이트화 글리코 사미노글리큐로난
DK0410326T3 (da) Genetisk styring af acetylering og pyruvylering af xanthangummi
GR3024416T3 (en) Process for the synthesis of semisynthetic glycosaminoglycans with heparin or heparan structure modified in position 2 of the alpha-L-iduronic-2-0-sulfate acid.
ITMI931175A1 (it) Polisaccaridi ad elevata attivita' antitrombotica e anticoagulante
DE3885504T2 (de) Teicoplaninderivate.
SU1541218A1 (ru) Способ получения производных декстрана
ES2043529A1 (es) Procedimiento para la obtencion de un polisacarido sulfato alcalino.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees